Penn Medicine Abramson Cancer Center

Penn Medicine Abramson Cancer Center. It is a national leader in cancer treatment, research, and education, consistently ranked among the top cancer hospitals in the United States by U.S. News & World Report. The center is an integral component of the University of Pennsylvania Health System and the Perelman School of Medicine at the University of Pennsylvania, leveraging the resources of a premier academic medical center. Its mission encompasses pioneering translational research, delivering multidisciplinary patient care, and training the next generation of oncologists.

History

The center's origins trace back to 1973 with the establishment of the University of Pennsylvania Cancer Center, a foundational effort to consolidate oncology efforts across the university. A transformative gift in 2002 from Leonard and Madlyn Abramson led to its renaming, providing substantial resources for expansion. Under the leadership of directors like John H. Glick and later Chi Van Dang, the center significantly grew its research portfolio and clinical footprint. Its history is marked by integration with the broader Penn Medicine enterprise, including the Hospital of the University of Pennsylvania and the Perelman School of Medicine at the University of Pennsylvania, fostering a unified approach to combating cancer.

Clinical care and research

Clinical care is delivered through disease-focused teams integrating medical, surgical, and radiation oncology, with specialists from the Perelman School of Medicine at the University of Pennsylvania providing expertise in areas like hematologic malignancies and solid tumors. The research enterprise is distinguished by a robust translational research model, rapidly moving laboratory discoveries into clinical trials. Pioneering work includes the development of CAR T-cell therapy, led by researchers like Carl June, which revolutionized the treatment of certain leukemias and lymphomas. The center also hosts a National Cancer Institute-designated comprehensive cancer center, supporting extensive basic science in cancer genetics, immunology, and virology.

Facilities and locations

The flagship clinical facility is located within the Perelman Center for Advanced Medicine on the campus of the Hospital of the University of Pennsylvania in West Philadelphia. This state-of-the-art building houses multidisciplinary clinics, advanced radiation oncology suites using technologies like proton therapy, and infusion centers. The center extends its reach through a network of community locations across the Philadelphia region and New Jersey, including the Penn Medicine Radnor facility and the Lancaster General Health partnership. Research activities are primarily conducted in adjacent buildings such as the Smilow Center for Translational Research and the Abramson Family Cancer Research Institute.

Notable achievements and innovations

The center is globally recognized for pioneering the first successful clinical application of CAR T-cell therapy for acute lymphoblastic leukemia, a landmark in immunotherapy. Researchers here, including Drew Weissman, whose foundational work on mRNA technology was critical to COVID-19 vaccine development, have made seminal contributions to biomedical science. It has been a leading site for trials in precision medicine, such as targeting the BCR-ABL gene in chronic myelogenous leukemia. The center's physicians and scientists have received numerous accolades, including the Lasker Award and recognition from the American Association for Cancer Research.

Affiliations and recognition

The center holds the prestigious "Comprehensive Cancer Center" designation from the National Cancer Institute, a marker of excellence in research, clinical care, and community outreach. It is a core member of national research consortia such as the ECOG-ACRIN Cancer Research Group and the Alliance for Clinical Trials in Oncology. Its faculty hold leadership roles in organizations like the American Society of Clinical Oncology and the American Society of Hematology. The center's clinical programs are consistently highly ranked by U.S. News & World Report, and it maintains educational affiliations for training fellows through the Perelman School of Medicine at the University of Pennsylvania. Category:Cancer centers in the United States Category:Penn Medicine Category:University of Pennsylvania Category:Medical and health organizations based in Philadelphia Category:1973 establishments in Pennsylvania